Company: RGNX
Filing Date: 2025-06-13
Form Type: S-8
Source: 0000950170-25-086259
Chunk: 4

Company: REGENXBIO Inc.
Filing Date: 2025-06-13
Form: S-8
Chunk 4
---
 required or permitted. We are not aware of any threatened litigation or proceeding that might result in a claim for such indemnification.

Item 7. Exemption from Registration Claimed.

Not applicable.

Item 8. Exhibits.

| Exhibit No. 
 4.1*        
 4.2*        | Description                                                                                                                                                                                               
 Restated Certificate of Incorporation (incorporated by reference from Exhibit 3.1 to the Company’s Current Report on Form 8-K, filed with the SEC on June 7, 2021).                                       
 Amended and Restated Bylaws (incorporated by reference from Exhibit 3.2 to the Company’s Current Report on Form 8-K, filed with the SEC on September 22, 2015).                                           |
|:------------|:----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 4.3*        | Specimen stock certificate evidencing the shares of Common Stock (incorporated by reference from Exhibit 4.1 to the Company’s Registration Statement on Form S-1, filed with the SEC on August 17, 2015). |
| 5.1         | Opinion and Consent of Covington & Burling LLP.                                                                                                                                                           |
| 23.1        | Consent of PricewaterhouseCoopers LLP, Independent Registered Public Accounting Firm.                                                                                                                     |
| 23.2        | Consent of Covington & Burling LLP (contained in Exhibit 5.1).                                                                                                                                            |
| 24.1        | Power of Attorney (contained on signature page hereto).                                                                                                                                                   |
| 99.1        | REGENXBIO Inc. 2025 Equity Incentive Plan.                                                                                                                                                                |
| 107         | Filing Fee Table.                                                                                                                                                                                         |

* Incorporated by reference

Item 17. Undertakings

The undersigned registrant hereby undertakes:

To file, during any period in which offers or sales are being made, a post-effective amendment to this Registration Statement:

To include any prospectus required by Section 10(a)(3) of the Securities Act of 1933;

To reflect in the prospectus any facts or events arising after the effective date of this Registration Statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the Registration Statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any